Team

From MakeSense to MatchBioTech.

The team moved from an international biosensor competition to cross-disciplinary prototype validation, clinical insight, and a focused translational direction in continuous L-DOPA monitoring.

KOL / partners MakeSense Society
SensUs 2025 · Analytical Performance · Global Champion

From MakeSense to MatchBioTech.

The team moved from an international biosensor competition to cross-disciplinary prototype validation, clinical insight, and a focused translational direction in continuous L-DOPA monitoring.

Research · Validation and PoC

Research Edition

Focused on research validation and PoC, proving the continuous biosensor pathway first.

Clinical · Clinical continuous monitoring

Clinical Edition

Links concentration feedback, movement data, and visit reports for clinical continuous monitoring scenarios.

Medical · Medicalization and multimodal sensing

Medical Edition

Moves toward medical-device validation and multimodal sensing, preserving an expandable small-molecule monitoring platform.

Cross-disciplinary support network

WiSe Lab, Zhao Lab, iHuman, ShanghaiTech BME, and the School of Life Science support the full-stack iteration from AI-driven biomaterial design to wearable monitoring.

Team development history

  1. 2024.11 MakeSense team formed
    • ShanghaiTech was invited to participate in SensUs 2025
    • The first full-stack cross-disciplinary team was formed
    • Members came from biology, chemistry, materials, computer science, electronic information engineering, and industrial design
    • Three mentors came from biology, biomedical engineering, and design
  2. 2025.08 Champion in the Netherlands
    • Won the SensUs 2025 international championship
    • Validated the biosensor verification path
    • Beat graduate teams from Cornell, ETH Zurich, TU Delft, and others
    • Made MakeSense history and broke the 10-year record
  3. 2025.08 Commercial exploration
    • Conducted a full SensUs commercialization assessment
    • Explored commercialization for the creatinine sensor project
    • Archived patents, papers, and technical materials
    • Started engagement across education, research, industry, and commercialization fields
  4. 2025.11 Shift to L-DOPA monitoring
    • Inspired by SensUs and validated by Parkinson's clinical KOLs
    • Started clinical-translation R&D for clinical and frontier detection
    • Launched the L-DOPA monitoring pipeline
  5. 2025.11 Full R&D testing
    • Relied on WiSe Lab and Zhao Lab
    • Worked with support from iHuman, ShanghaiTech BME, and the School of Life Science
    • Advanced full-stack R&D from AI-driven biosensitive-material design to wearable monitoring
  6. 2026.03 Shanghai MatchBioTech founded
    • The team's technical innovation path was validated and in-vitro prototype tests succeeded
    • Hospital, patient, and industry research was completed
    • Collaboration with the Shanghai Clinical Research Center was established
    • The StrivePD China ecosystem outlook was established
    • Formal commercialization exploration began
  7. 2026.05 Product moves toward animal-experiment prep
    • Hardware and sensitive materials are advancing together
    • The product is about to enter animal experiments
CTA

Talk to us.

We are looking for first-cohort research-edition customers (CROs, pharma, academic labs) and neurology KOLs.

KOL / partners Press / careers